Crossject SA
Crossject Appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment
Tony Tipton has over 25 years of experience across the key pillars of commercial pharmaceuticals business, encompassing corporate leadership, business development, market access, sales force leadership, marketing and trade operations.
